1. Home
  2. LGIH vs MPLT Comparison

LGIH vs MPLT Comparison

Compare LGIH & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$45.62

Market Cap

984.3M

ML Signal

HOLD

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$29.30

Market Cap

811.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGIH
MPLT
Founded
2003
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
984.3M
811.3M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
LGIH
MPLT
Price
$45.62
$29.30
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$75.90
$32.67
AVG Volume (30 Days)
398.7K
285.9K
Earning Date
04-28-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.12
N/A
Revenue
$1,705,504,000.00
N/A
Revenue This Year
$2.32
N/A
Revenue Next Year
$17.94
N/A
P/E Ratio
$14.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.55
$12.24
52 Week High
$69.42
$33.28

Technical Indicators

Market Signals
Indicator
LGIH
MPLT
Relative Strength Index (RSI) 59.30 62.94
Support Level $41.82 $15.34
Resistance Level $48.83 N/A
Average True Range (ATR) 2.26 2.82
MACD 1.05 0.23
Stochastic Oscillator 77.50 67.50

Price Performance

Historical Comparison
LGIH
MPLT

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.

Share on Social Networks: